The historic rise of Viagra has consistently remained a symbol of pharmaceutical success, but its position within the broader market now raises questions about long-term yields . Copycat versions are eroding exclusivity , prompting anxieties that investing in companies closely tied to Viagra's previous standing could be a speculative strategy, espe